9GOD | pdb_00009god

Crystal structure of DPP9 in complex with N-phosphono-(S)-3-aminopiperidine-2-one-based inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.49 Å
  • R-Value Free: 
    0.219 (Depositor), 0.210 (DCC) 
  • R-Value Work: 
    0.170 (Depositor) 
  • R-Value Observed: 
    0.171 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9GOD

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors.

Sewald, L.Tabak, W.W.A.Fehr, L.Zolg, S.Najdzion, M.Verhoef, C.J.A.Podlesainski, D.Geiss-Friedlander, R.Lammens, A.Kaschani, F.Hellerschmied, D.Huber, R.Kaiser, M.

(2025) Nat Commun 16: 3208-3208

  • DOI: https://doi.org/10.1038/s41467-025-58493-z
  • Primary Citation Related Structures: 
    9GOC, 9GOD, 9GOH, 9GON

  • PubMed Abstract: 

    Covalent chemical probes and drugs combine unique pharmacologic properties with the availability of straightforward compound profiling technologies via chemoproteomic platforms. These advantages have fostered the development of suitable electrophilic "warheads" for systematic covalent chemical probe discovery. Despite undisputable advances in the last years, the targeted development of proteome-wide selective covalent probes remains a challenge for dipeptidyl peptidase (DPP) 8 and 9 (DPP8/9), intracellular serine hydrolases of the pharmacologically relevant dipeptidyl peptidase 4 activity/structure homologues (DASH) family. Here, we show the exploration of the natural product Sulphostin, a DPP4 inhibitor, as a starting point for DPP8/9 inhibitor development. The generation of Sulphostin-inspired N-phosphonopiperidones leads to derivatives with improved DPP8/9 inhibitory potency, an enhanced proteome-wide selectivity and confirmed DPP8/9 engagement in cells, thereby representing that structural fine-tuning of the warhead's leaving group may represent a straightforward strategy for achieving target selectivity in exoproteases such as DPPs.


  • Organizational Affiliation
    • Chemical Biology, Center of Medical Biotechnology, Faculty of Biology, University Duisburg-Essen, Essen, Germany.

Macromolecule Content 

  • Total Structure Weight: 393.54 kDa 
  • Atom Count: 27,151 
  • Modeled Residue Count: 3,245 
  • Deposited Residue Count: 3,404 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Dipeptidyl peptidase 9
A, B, C, D
851Homo sapiensMutation(s): 0 
Gene Names: DPP9DPRP2
EC: 3.4.14.5
UniProt & NIH Common Fund Data Resources
Find proteins for Q86TI2 (Homo sapiens)
Explore Q86TI2 
Go to UniProtKB:  Q86TI2
PHAROS:  Q86TI2
GTEx:  ENSG00000142002 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ86TI2
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1INH
(Subject of Investigation/LOI)

Query on A1INH



Download:Ideal Coordinates CCD File
CA [auth C],
E [auth A],
P [auth B],
PA [auth D]
ethoxy-[2-(4-pentylphenyl)sulfanylethyl]phosphinous acid
C15 H25 O2 P S
FXKUIYATLFLECN-GOSISDBHSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
DA [auth C]
EA [auth C]
F [auth A]
AA [auth B],
BA [auth B],
DA [auth C],
EA [auth C],
F [auth A],
FA [auth C],
G [auth A],
GA [auth C],
H [auth A],
HA [auth C],
I [auth A],
IA [auth C],
J [auth A],
JA [auth C],
K [auth A],
KA [auth C],
L [auth A],
LA [auth C],
M [auth A],
MA [auth C],
N [auth A],
NA [auth C],
Q [auth B],
QA [auth D],
R [auth B],
RA [auth D],
S [auth B],
SA [auth D],
T [auth B],
U [auth B],
V [auth B],
W [auth B],
X [auth B],
Y [auth B],
Z [auth B]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
O [auth A],
OA [auth C]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.49 Å
  • R-Value Free:  0.219 (Depositor), 0.210 (DCC) 
  • R-Value Work:  0.170 (Depositor) 
  • R-Value Observed: 0.171 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 89.306α = 65.24
b = 106.746β = 71.02
c = 121.482γ = 76.71
Software Package:
Software NamePurpose
autoPROCdata reduction
XDSdata reduction
autoPROCdata scaling
Aimlessdata scaling
REFMACrefinement
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
German Research Foundation (DFG)GermanyCRC1430, Project number 424228829

Revision History  (Full details and data files)

  • Version 1.0: 2025-07-16
    Type: Initial release